Wandercraft Receives FDA Clearance for Atalante, a Self-Balancing Device for Hands-Free Movement


Self-stabilizing rehabilitation device available for stroke patients

Wandercraft, a leading company in healthcare exoskeletons, announced today that the US Food and Drug Administration (FDA) cleared the gait-training exoskeleton, Atalante, for stroke rehabilitation. Since 2020, the French company has already deployed 22 copies of its Atalante exoskeleton in clinical settings, and five in other research settings. The year 2022 has seen major growth for the deep tech, with more than 330 patients treated and 12 exoskeletons deployed, more deployments than in Wandercraft's entire history.

Every year, more than 795,000 people in the United States have a stroke, a leading cause of serious long-term disability[1].

"Strokes reduce mobility in more than half of stroke survivors aged 65 and older. With the input of many healthcare teams worldwide, Wandercraft has designed a next-generation, self-balancing, multi-directional gait exoskeleton to enable intensive, early, and specific gait training for neurorehabilitation therapy and improve recovery in stroke patients, especially for those with significant upper extremity involvement," said Matthieu Masselin, CEO, Wandercraft. "This clearance is a significant milestone for Wandercraft, but it's only the start, as we are working on more indications." 

CE-marked since 2019, Atalante has been used to treat hundreds of patients with various medical conditions across multiple European rehabilitation hospitals. Its unique self-balancing feature enables patients to move in multiple directions hands-free, without an assistive device, and includes a dynamic balance mode unavailable elsewhere in the market.

"I am happy to hear the Wandercraft Atalante exoskeleton has been approved for use in the U.S. market. It will add an innovative treatment option for stroke patients, especially for those with significant upper extremity involvement needing gait rehabilitation," explained Arun Jayaraman, PT, PhD, Executive Director of Technology & Innovation Hub at Shirley Ryan Ability Lab.

"Quadrant led Wandercraft's last funding round, in large part, to bring this breakthrough technology to the American market, which is by far the largest in the world," said Alan Quasha, Chairman and CEO, Quadrant Management. "Now with the FDA's 510(k) clearance, Wandercraft has the opportunity to significantly scale its business within the next 12-24 months."

"I'm thrilled to see that the Wandercraft Atalante exoskeleton is receiving FDA approval. This means that many patients with paralysis in the United States will be able to take advantage of this technology to help them recover. We're also excited to partner with Wandercraft's team to further explore this technology and to help as many people as we can," commented Kenneth Ngo, MD, FAAPM&R, Medical Director, Brooks Rehabilitation Hospital.

Wandercraft is now launching its commercial operations in the U.S. with a corporate office in New York, led by Matthieu Masselin, and expects to deliver the first Atalante exoskeletons during the first quarter of 2023. 

About Wandercraft

Founded in 2012, Wandercraft is a patient-focused company with the goal of providing better access to mobility and autonomy for patients with gait disorders. Wandercraft builds autonomous walking exoskeletons. Its first version, Atalante, was commercialized in 2019 and is used by rehabilitation and neurological hospitals in Europe and clinical research institutes in the USA. Atalante provides innovative care for many patients based on realistic, hands-free, multi-direction locomotion.

For more information, please visit www.wandercraft.eu.

  1. [1]Tsao CW, Aday AW, Almarzooq ZI, Alonso A, Beaton AZ, Bittencourt MS, et al. Heart Disease and Stroke Statistics—2022 Update: A Report From the American Heart AssociationCirculation. 2022;145(8):e153-e639.
Contact Information:
Jean-François kitten
Public relations
[email protected]
+33(0) 6 11 29 30 28

Gary Viles
VP of commercial operations Americas
[email protected]
+1(813) 435-0772
Related Files
3 (3).jpg

Original Source: Wandercraft Receives FDA Clearance for Atalante, a Self-Balancing Device for Hands-Free Movement

Share post:

how to submit press releasehow to submit press release


More like this

Jane Fonda is not looking forward to Barbarella remake

Jane Fonda has zero interest in discussing the...

HealthTech Startup Healistic Raises £1M in Funding and Launches First-of-Its-Kind, UK-Based App to Fuel the ‘Open Healthcare’ Revolution

Healistic is building a first-of-its-kind healthcare super-app, connecting healthcare and insurance providers to end users via dynamic digital solutions. The HealthTech app's first offering provides medicine and personal care product home delivery, from medication and supplements to cosmetics and personal care - all in less than 45 minutes to the patient's doorstep.

Healistic, an innovative HealthTech mobile app and the first pharma-based speedy delivery service in the UK, announced £1M in pre-seed funding from leading international investors today. Powered by the belief that healthcare should be effortless and immediately available to everyone, Healistic is building an all-in-one universal healthcare platform, providing a seamless experience in an asset-light marketplace business model. From a user perspective, the app is already live for iOS and Android and offers thousands of healthcare products (incl. P-Meds and soon prescription medications), delivered conveniently to the customer's doorstep in under 45 minutes - an unparalleled user experience in the UK. No commute to the pharmacy, no queues, no risk of transmission, and no overheard intimate conversations when ordering at the counter.

Healistic has partnered with independent pharmacies across London, enabling them to access a digital channel and customer base they otherwise couldn't reach. Healistic uses riders on eco-friendly bikes to deliver within 45 minutes. Founded by Daniel Bulkin, a London-based serial HealthTech Entrepreneur and ex-Private Equity investor in the Technology & Healthcare space, Healistic aims to address unfulfilled demand as a category leader. From consumer research1, Bulkin found that customers are demanding a healthcare experience that is omni-channel, convenient, and fast, allowing them to understand and control their own healthcare management. 

Healistic is on a mission to become the go-to D2C HealthTech mobile app, offering an end-to-end digital patient home. This will take shape as a scalable marketplace model with SaaS tech solutions to connect pharmacies, insurers, and corporations with end users. The launch of Healistic translates into a £100bn+ market opportunity, with strong digitalisation and growth potential2.

The mobile app has initially launched in London. The plan is to expand into other cities across the UK this year. Healistic will also continue to build on its initial offering, with plans to implement speedy prescription delivery, tele-health consultations with GPs and nutritionists, and insurance claim management, as it moves towards a full-service digital healthcare app.

Daniel Bulkin, CEO of Healistic, said: "This funding round has allowed us to introduce a product to market that will serve the digital patient at a crucial time. Against a backdrop of increased uncertainty within the NHS, including strikes and supply chain issues, Healistic aims to alleviate these pressures by connecting patients to the appropriate healthcare solutions through a trusted, centralised system. We believe that immediate healthcare should be accessible to everyone. Healistic is building a category leader in the 'Open Healthcare' revolution, a parallel to the 'Open Banking' revolution, which began in the last decade." 

Speaking of the funding, Christian Hieronimi, Healistic Investor and serial HealthTech Entrepreneur, added: "The launch of Healistic signals a true step in the direction of a deeply integrated and interconnected digital patient journey. The platform empowers patients to become active managers of their health and creates a comprehensive system to take the treatment, prescription, and therapy process to the next level."

Kevin Heath, Healistic Advisor and ex-Boots Executive Board Director, said, "As a first-mover in the UK healthcare space, Healistic is providing a modern and convenient customer experience while helping partner pharmacies expand their radius and customer reach. Healistic's asset-light model will allow for quick expansion in terms of geography and service offering, which will be highly valuable for consumers and healthcare professionals."   


Editor's notes:

High-resolution screenshots, logos and headshots can be found here: https://www.dropbox.com/sh/jwb9if4hbstw52x/AAC-rkNrRddwgQqiE6hReI9Ya?dl=0

1 Source: McKinsey & Company - Pharmacy's new era - in the home

2 Sources: Bain and Company, Grand View Research, Cision, Statista

About Healistic:
Healistic is building the 'open healthcare' revolution - a HealthTech super-app connecting healthcare providers and insurances to end users via dynamic digital solutions. The app offers an accessible, seamless experience, with under 45 minutes delivery, and will soon add virtual consultations with GPs and prescription delivery to its services. Its vision for the future includes health insurance pre-approval, claims management and financing, centralised and accessible patient records, data analytics, tailored recommendations for users, and an ad platform for partners. Healistic is quickly becoming a category leader in the UK, with a strong vision to expand services across the country, and globally after that. To follow the Healistic journey, visit: https://www.healistic.net

Media Contact:

UK: Gemma Dodd: [email protected]

Lili Dewrance: [email protected]

US: Melissa Tirey: [email protected]

Contact Information:
Melissa Tirey
[email protected]
+1 646 823 6776

Lili Dewrance
[email protected]

Gemma Dodd
[email protected]
+44 7585 126262

Original Source: HealthTech Startup Healistic Raises £1M in Funding and Launches First-of-Its-Kind, UK-Based App to Fuel the 'Open Healthcare' Revolution

Paramount 2023 Film Schedule

It was a good year for Paramount Pictures in...

Ombudsman’s Office holds First Annual Conference:”Government and Stakeholders – Finding Solutions Together”

Ombudsman’s Office holds First Annual Conference Originally published at https://www.dhs.gov/ombudsmans-office-holds-first-annual-conference